Carclo Regulatory News (CAR)

15 November 2022

Carclo plc

("the Company" or "Carclo")

Directorate Change

Retirement and Appointment of Chief Financial Officer

Carclo plc (the "Company" or "Carclo") announces that Phil White has given notice of his retirement and has stepped down from his role as Chief Financial Officer and as a Director of the Company with effect from 14 November 2022. Phil will remain with the Company until his retirement in June 2023 in order to ensure a smooth transition to the new CFO.

The Board of Carclo (the "Board") is pleased to announce the promotion of David Bedford to Chief Financial Officer and appointment as a Director of the Company with effect from 14 November 2022. David joined Carclo in September 2022 as the Chief Financial Officer of the CTP Division.

David is a chartered accountant and holds a degree in Economics & Accounting from the University of Bristol. He brings extensive UK and international finance leadership experience gained within a range of well-respected organisations. His most recent role was as Group Finance Director of Synectics plc from 2020 to 2022. Having qualified with Deloitte & Touche in 1994, David joined Price Waterhouse's corporate finance group. David held a number of senior finance positions within IMI Precision, the largest division of IMI Plc, between 2005 and 2020. Prior to IMI, David spent 7 years with Jaguar Land Rover.

Frank Doorenbosch said:

"On behalf of the Board I would like to thank Phil for his service to the Company through what has been a challenging period and I wish him well for the future. I am delighted to welcome David to the Board. His experience will be a great asset to the business and I look forward to working with him to deliver value to all of the Company's stakeholders."

There is no further information required to be disclosed pursuant to paragraph LR 9.6.13R of the Listing Rules of the Financial Conduct Authority in connection with David's appointment.

About Carclo plc

Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange. The Group is a global provider of value-adding engineered solutions for the medical, optical and aerospace industries.

LEI: 21380078MEM399JPI956

Enquiries: